We could not find any results for:
Make sure your spelling is correct or try broadening your search.
In the United States, a new drug application, or NDA, is the vehicle through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing. And news that...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDP Canada NewsWire TORONTO, le 6 juin 2024 TORONTO, le 6 juin 2024 /CNW/ - L'OCRI...
Canadian Investment Regulatory Organization Trading Halt - MDP Canada NewsWire TORONTO, June 6, 2024 TORONTO, June 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Medexus...
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MDP Canada NewsWire TORONTO, le 6 juin 2024 TORONTO, le 6 juin 2024 /CNW/ - Reprise...
Canadian Investment Regulatory Organization Trade Resumption - MDP Canada NewsWire TORONTO, June 6, 2024 TORONTO, June 6, 2024 /CNW/ - Trading resumes in: Company: Medexus Pharmaceuticals...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDP.DB Canada NewsWire TORONTO, le 16 oct. 2023 TORONTO, le 16 oct. 2023 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - MDP.DB Canada NewsWire TORONTO, Oct. 16, 2023 TORONTO, Oct. 16, 2023 /CNW/ - The following issues have been halted by CIRO: Company:...
TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF), is pleased to announce that it has entered into an...
TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom...
TORONTO and CHICAGO, April 11, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce preliminary revenue estimates for the company’s fourth fiscal...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.75 | 21.4285714286 | 3.5 | 4.25 | 3.42 | 133437 | 3.86231981 | CS |
4 | 1.36 | 47.0588235294 | 2.89 | 4.25 | 2.6 | 58014 | 3.6429275 | CS |
12 | 1.73 | 68.6507936508 | 2.52 | 4.25 | 1.72 | 40925 | 2.9165216 | CS |
26 | 1.92 | 82.4034334764 | 2.33 | 4.25 | 1.72 | 31408 | 2.7351025 | CS |
52 | 1.37 | 47.5694444444 | 2.88 | 4.25 | 1.47 | 41007 | 2.19292616 | CS |
156 | 1.52 | 55.6776556777 | 2.73 | 4.25 | 0.88 | 37751 | 2.10398568 | CS |
260 | -3.13 | -42.4119241192 | 7.38 | 7.9 | 0.88 | 38942 | 2.44437485 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions